NCT04804007View on ClinicalTrials.gov

Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Germ Cell TumorNon-seminomatous Germ Cell TumorOvarian Germ Cell Tumor
Interventions
DRUG

Etoposide

etoposide will be provided with prescription for etoposide 50mg orally daily for 21 days out of 28 day cycles. Cycles will be repeated every 4 weeks for a total of 3 cycles.

Trial Locations (1)

46202

RECRUITING

Indiana University Melvin & Bren Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Nabil Adra

OTHER